In Hormone replacement therapy Hormone placement therapy (HRT) is a treatment to relieve symptoms of menopause such as hot flushes, night sweats, mood swings, vaginal dryness, and reduced sex drive. Since menopause can last for several years, this treatment can make a big improvement to your daily life and mood. Estrogen is one of two important hormones (the other is progesterone) used in this treatment. You should use this medicine as it is prescribed, and for as long as it is prescribed by your doctor. In Post menopausal osteoporosis Osteoporosis is a common condition that weakens bones, making them fragile and more likely to break. It often occurs in women after menopause. Tibomax 2.5mg Tablet helps maintain bone density and reduces your risk of breaking a bone. You should use this medicine as it is prescribed, and for as long as it is prescribed by your doctor. You can help improve the strength of your bones by doing regular exercise (especially weight-bearing exercise), eating healthy foods containing calcium and Vitamin D, and reducing your consumption of alcohol and tobacco. Supplements of calcium and Vitamin D3 are also effective.
It is unsafe to consume alcohol with Tibomax 2.5mg Tablet.
Tibomax 2.5mg Tablet is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
Information regarding the use of Tibomax 2.5mg Tablet during breastfeeding is not available. Please consult your doctor.
Tibomax 2.5mg Tablet does not usually affect your ability to drive.
There is limited information available on the use of Tibomax 2.5mg Tablet in patients with kidney disease. Please consult your doctor.
There is limited information available on the use of Tibomax 2.5mg Tablet in patients with liver disease. Please consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Serum Institute Of India Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Organon (India) Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Cipla Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)